| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-06 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
9e-05 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |